352 related articles for article (PubMed ID: 36651686)
1. Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents.
Strawn JR; Mills JA; Poweleit EA; Ramsey LB; Croarkin PE
Pharmacotherapy; 2023 Jul; 43(7):675-690. PubMed ID: 36651686
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant Tolerability in Pediatric Anxiety and Obsessive-Compulsive Disorders: A Bayesian Hierarchical Modeling Meta-analysis.
Mills JA; Strawn JR
J Am Acad Child Adolesc Psychiatry; 2020 Nov; 59(11):1240-1251. PubMed ID: 31682918
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.
Strawn JR; Mills JA; Sauley BA; Welge JA
J Am Acad Child Adolesc Psychiatry; 2018 Apr; 57(4):235-244.e2. PubMed ID: 29588049
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.
Strawn JR; Welge JA; Wehry AM; Keeshin B; Rynn MA
Depress Anxiety; 2015 Mar; 32(3):149-57. PubMed ID: 25449861
[TBL] [Abstract][Full Text] [Related]
5. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis.
Stefánsdóttir ÍH; Ivarsson T; Skarphedinsson G
Nord J Psychiatry; 2023 Feb; 77(2):137-146. PubMed ID: 35587815
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
8. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
[TBL] [Abstract][Full Text] [Related]
9. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
10. Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis.
Gosmann NP; Costa MA; Jaeger MB; Frozi J; Spanemberg L; Manfro GG; Cortese S; Cuijpers P; Pine DS; Salum GA
Psychol Med; 2023 Jul; 53(9):3783-3792. PubMed ID: 37278215
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.
Locher C; Koechlin H; Zion SR; Werner C; Pine DS; Kirsch I; Kessler RC; Kossowsky J
JAMA Psychiatry; 2017 Oct; 74(10):1011-1020. PubMed ID: 28854296
[TBL] [Abstract][Full Text] [Related]
12. SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents.
Hosenbocus S; Chahal R
J Can Acad Child Adolesc Psychiatry; 2011 Feb; 20(1):60-7. PubMed ID: 21286371
[TBL] [Abstract][Full Text] [Related]
13. Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths.
Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
JAMA Pediatr; 2017 Dec; 171(12):1200-1207. PubMed ID: 29049533
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-Induced Activation in Children and Adolescents: Risk, Recognition and Management.
Luft MJ; Lamy M; DelBello MP; McNamara RK; Strawn JR
Curr Probl Pediatr Adolesc Health Care; 2018 Feb; 48(2):50-62. PubMed ID: 29358037
[TBL] [Abstract][Full Text] [Related]
15. Advances in Pharmacotherapy for Pediatric Anxiety Disorders.
Nicotra CM; Strawn JR
Child Adolesc Psychiatr Clin N Am; 2023 Jul; 32(3):573-587. PubMed ID: 37201968
[TBL] [Abstract][Full Text] [Related]
16. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
[TBL] [Abstract][Full Text] [Related]
17. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
18. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
[TBL] [Abstract][Full Text] [Related]
20. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
